Skip to main content
Ronald Witteles, MD, Cardiology, Palo Alto, CA, Stanford Health Care

RonaldWittelesMD

Cardiology • Palo Alto, CA

Adult Congenital Heart Disease, Cardiac Electrophysiology, Heart Failure & Transplantation

Assistant Professor, Medicine - Cardiovascular Medicine, Stanford University Medical Center

Join to view full profile

Dr. Witteles is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Witteles' full profile

Already have an account?

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 2004 - 2007
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2000 - 2003
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2000

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2001 - 2025
  • OR State Medical License
    OR State Medical License 2020 - 2022
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
  • Most Compassionate Doctor American Registry
  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Long-Term Outcomes and Organ Responses with Daratumumab Therapy in Previously Treated Patients with AL Amyloidosis
    Ronald Witteles, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Favorable Long-Term Outcomes after Daratumumab Discontinuation in AL Amyloidosis Patients Achieving Deep Responses
    Ronald Witteles, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Ted Talk (No Slides): What do I Think? 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
  • Get the Diagnosis Right: Identifying Amyloidosis in Your Patients 
    2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019

Authored Content

  • Summary of Clinical Trials for the Prevention and Treatment of Cardiomyopathy Related to Anthracyclines and HER2-Targeted AgentsJuly 2020
  • Summary of Clinical Trials for the Prevention and Treatment of Cardiomyopathy Related to Anthracyclines and HER2-Targeted AgentsJuly 2020

Press Mentions

  • Atorvastatin Cut Anthracycline Cardiac Dysfunction in Lymphoma
    Atorvastatin Cut Anthracycline Cardiac Dysfunction in LymphomaMarch 4th, 2023
  • Global Cardio-Oncology Viewpoints ‘Contextualize’ ESC Guidelines
    Global Cardio-Oncology Viewpoints ‘Contextualize’ ESC GuidelinesDecember 12th, 2022
  • COVID-19 Vaccine Rollout Plagued by Protests, Failed Technology and Front-Line Workers Missing Out
    COVID-19 Vaccine Rollout Plagued by Protests, Failed Technology and Front-Line Workers Missing OutDecember 22nd, 2020
  • Join now to see all

Professional Memberships

Hospital Affiliations

Dr. Ronald Witteles, Dr. Ronald Witteles, MD, Dr. R Witteles